The pharmaceutical sector has been at the crux of numerous globalization debates, among which are the offshoring of clinical trials and the establishment of an international institutional infrastructure designed to protect intellectual property rights (IPR). At the end of the 20th ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles